A de novo hexokinase 1 (HK1) variant presenting as Boucher-Neuhäuser syndrome

Am J Med Genet A. 2023 Feb;191(2):624-629. doi: 10.1002/ajmg.a.63045. Epub 2022 Dec 21.

Abstract

Boucher-Neuhäuser syndrome (BNHS) is characterized by chorioretinal dystrophy, hypogonadotropic hypogonadism, and cerebellar dysfunction and atrophy. The disorder has been associated with biallelic pathogenic variants in the patatin-like phospholipase domain-containing protein 6 (PNPLA6) gene. We present an individual with a clinical diagnosis consistent with BNHS who lacked any PNPLA6 variants but on quartet family exome sequencing had a de novo variant in the hexokinase 1 (HK1) gene (NM_000188.2 [GRCh37/hg19]: g.71139826G>A, c.1240G>A, p.Gly414Arg), suggesting genetic heterogeneity for BNHS. Longitudinal follow-up indicated neurological deterioration, neuropsychiatric symptoms, and progressive cerebellar atrophy. The BNHS phenotype overlaps and expands the known HK1 genotypic and phenotypic spectrum. Individuals with variants in HK1 should undergo evaluation for hypogonadotropic hypogonadism, potentially amenable to treatment.

Keywords: Boucher-Neuhäuser syndrome; cerebellar ataxia; cerebellar atrophy; chorioretinal dystrophy; hypogonadotropic hypogonadism.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Atrophy
  • Hexokinase / genetics
  • Humans
  • Hypogonadism* / diagnosis
  • Hypogonadism* / genetics
  • Klinefelter Syndrome*
  • Spinocerebellar Ataxias* / genetics

Substances

  • Hexokinase

Supplementary concepts

  • Chorioretinal Dystrophy, Spinocerebellar Ataxia, and Hypogonadotropic Hypogonadism